esp given management upbeat tone cagni view macro
trend part world headwind emerg market
categori growth rate appear trend around vs
msd prior howev increasingli concern cl poor
fundament perform last qs also reflect
lacklust execut step local brand competit
management confid cl on-going initi incl better price
step natur
less optimist
initi drive improv maintain market perform
innov
weak organ sale growth disappoint gross margin
cl adj ep y/i essenti in-lin vs
our/consensu est howev top-lin growth
continu disappoint organ sale growth
easier comparison contrari cl histor trend
organ sale growth predomin driven develop
market overal incl growth north america
although question much ultim reflect truli
emerg market organ sale growth emerg
market price mere lead us wonder cl
troubl take price particularli time commod
inflat continu increas cl product could lose
luster consum face increasingli sophist
local competitor margin also disappoint gross
margin y/i vs est continu
pressur higher raw materi cost final although somewhat
anticip cl lower guidanc lsd organ sale
growth vs lsd-msd prior adj gross margin
vs prior concern cl alreadi
conced sales/margin growth weaker-than-expect
earli year lower ep est
also lower price target
impli cl trade premium slightli
premium believ justifi
emerg market organ sale growth
give us pausemgmt posit outlookemerg market
organ sale growth weak continu growth
alreadi lacklust growth result
latin america disappoint organ sale growth
volume declin mexico due part heighten
competit activ said management continu see signific
potenti emerg market optimist natur
innov support re-acceler growth trend
weaken believ good first step although
await evid turn becom increment
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud restructur charg one-tim item
compani prioriti stock list
compani data secur llc estim reuter
growth acceler north america albeit easi comp cl post organ
sale growth north america strongest growth segment sinc well
ahead though note easi comparison organ sale
growth furthermor growth entir volum driven vol
off-set price suggest cl like mani hpc peer remain hard-press
come take price manag attribut solid volum perform easi y/i
comparison vs signific retail inventori destock return solid categori
growth overal cl gain share categori share flat y/i
manag highlight innov pipelin give confid continu momentum
balanc said find share trend encourag also wonder cl
larg benefit short-liv recoveri north american fundament sever
sequenti quarter weak
cl invest thesi track record stabil entir
immun macroeconom volatil
cl one world recogniz consum product compani oral care person care
home care pet nutrit product purchas two-third world household
compani global well ahead ko believ cl return
annual organ growth algorithm post low-double-digit fx neutral ep growth long
term given follow unmatch distribut platform across emerg market half
net sale per-capita outpac develop market long-stand track
record achiev product save cost effici expect compani fund
growth cost-sav program remain import contributor gross margin estim
individu contribut gross margin basi point bp annual next sever
year reflect increasingli streamlin global manufactur footprint continu invest
rigor analyt capabl said disappoint cl weaker-than-expect result
concern cl may face pressur across global oper previous
anticip bottom line continu view cl track record oper stabil favor
although today result clearli indic cl immun
cl ep essenti in-lin organ sale growth continu disappoint ep
y/i compar our/consensu estim organ sale growth
expect vs estimates/street estim
show cl immun macroeconomic uncertainti local competit
slow emerg market drag organ sale growth organ sale growth
driven volum slow vs price flat price improv sequenti
vs price first time price neg sinc emerg
market organ sale growth slowest sinc least far back
model goe driven flat volum develop market perform better consecut quarter
sequenti improv organ sale growth behind volum
price driven solid volum growth north america
categori growth slow emerg market cl saw develop market categori growth
howev emerg market categori growth slow msd
previous overal global categori growth low-end manag long-
term expect categori
top-lin guidanc lower cl expect organ sale growth low-singl digit
prior rang lsd msd sequenti improv throughout
balanc year impli cl organ sale growth like
low-end long-term top-lin algorithm lower januari
gross margin remain pressur y/i gross margin
disappoint come estim driven higher raw packag materi
partial off-set fund growth cost save result higher expect commod
manag lower gross margin outlook expect improv
vs prior guidanc expans fund growth save benefit price
expect off-set raw materi inflat howev note
manag guidanc also assum raw materi includ oil declin vs
ep guidanc reiter cl expect organ sale growth increas lsd prior
lsd-msd drive msd net sale growth gross margin expect increas y/i
prior advertis expect absolut dollar percentag sale
digit repres media spend combin tax rate unchang
manag continu call ep growth
market share trend remain strong y/i global cl continu hold
share posit global oral market ytd share y/i share
global toothpast y/i share global manual toothbrush
y/i cl toothpast share y/i manual
toothbrush cl share expand y/i cl also note progress
multipl key countri includ brazil cl toothpast share y/i asia cl
toothpast share improv vs largest countri europ saw toothpast share
gain sever countri includ franc germani said cl appear lose share
china mexico india australia
promot activ emerg market grow manag mention competit
activ grow global categori growth slow key market manufactur seek
gain share shrink market typic cl defend share case particularli
latam competitor promot aggress cl chose particip applaud
manag disciplin follow aggress promot worri could indic
long-term pressur profit cl categori
focu remain four fundament cl continu make progress four
step introduc remain focu includ increas
advertis spend behind impact creativ innov especi toothpast
natur invest e-commerc aggress maxim product view
step encourag although await evid progress becom increment
posit
despit concern growth believ cl remain highli compet oper
even disappoint growth still believ cl remain one compet em oper
broader consum strong market share decad oper expertis
uncertainti across em like persist expect cl ultim prevail focus
consum engag introduc value-ad innov capit effici
fund new growth
cl show vulner emerg market cl report adjust ep y/i
vs our/consensu est organ sale growth disappoint yet
well estimate/consensu overal advertis spend littl light
y/i sale segment organ sale growth mix north america
well ahead estimate latin america well estimate flat volume
growth europ vs estimate asia pacif flat vs estimate africa eurasia
vs estimate hill vs estimate gross margin pressur
y/i estimate reflect higher raw materi packag cost overal
think today result disappoint organ sale growth includ emerg
market mere show cl despit compet global consum product leader
remain vulner macroeconom uncertainti addit think increasingli
sophist set local competitor maintain market perform
compani report secur llc
exhibit cl ebit trend segment
note figur reflect oper incom segment/company-wid compani report well fargo
market growth soft past americaeuropelatin americaasia pacificafrica/eurasiahil sebit margin colgate-palmol compani
exhibit cl organ sale trend segment
exhibit cl histor guidanc
forward ev-to-ebitda absolut rel updat price target impli ev-
to-ebitda multipl repres premium compani current multipl
furthermor cl current trade premium rel hpc peer group forward
ev/ebitda multipl basi compar premium hpc group averag
forward ev/ebitda basi premium hpc group averag forward ev/ebitda
forward price-to-earnings absolut rel price-to-earnings multipl target premium
compani current multipl discount one-year histor averag
forward price-to-earnings multipl cl current trade premium rel hpc peer group
forward price-to-earnings multipl basi compar premium hpc group averag
forward price-to-earnings basi premium hpc group averag forward price-to-earnings basi
sum-of-the-part discount also valu cl base sum-of-the-part dcf
analysi better understand compani growth opportun particularli latin america hill
base analysi believ cl worth north america segment worth
europ segment worth latin america segment worth
asia pacif segment worth africa eurasia segment worth
hill segment worth
guidanc provid januari call fy revenu growth lsd-msd impact margin bp vs ly inflationadvertisingup rel absolutelyup rel bp vs ly growth dollar basi ldd around around impact profittax provid octob call januari call april call juli call octob call fy revenu growth end rangemodestli volum impact revenueslight margin expansionhigh end rang high end rang end bp vs ly inflationadvertisingup rel absolutelyup rel absolutelyup rel absolutelyup rel absolut sequenti ramp vs bp vs ly growth dollar basi dd lsd lsd lsd lsd flat impact profittax reposimilar guidancefi guidanc colgate-palmol compani
graph factset secur llc
recent nielsen data cl
cl volum average price/unit growth y/i
cl dollar share y/i chang
chart nielsen xaoc includ c-store secur llc
ev/ebitda multipl ntm ev/ebitda current average average price-to-earnings multipl ntm price-to-earnings current average average sale y/yavg eq price y/ydollar sale y/i sold promo sold promo y/ydollar sharedollar share y/i bp retailperiod end end end end end end end soap-light combin channel data chang bp dollar share cosmet household person
recent emerg market nielsen data cl
exhibit cl categori result period end categori retail sale
nielsen scantrack total emerg market secur llc
exhibit cl emerg market valu sale volum average price per growth
note growth rate exclud brazil prior
nielsen scantrack total emerg market secur llc
exhibit cl emerg market valu share y/i chang
nielsen scantrack total emerg market secur llc
recent european nielsen data cl
exhibit cl european summari data week end
cl european eq volum average price/eq growth y/i
cl european valu share y/i chang
nielsen esp total europ secur llc
compani report secur llc estim
profit- inc oper ens relat postretir attribut non-control incom minor share eps- per america ex ex america ex pacif ex ex ex net net sale ex ex percent salescost good revenu build unless sale colgate-palmol compani
compani report secur llc estim
segment data net organ sale unless note north salesnorth sale ex-currencynorth sale growthnorth sale growth ex-currencynorth net salesnorth data incomenorth segment net segment ebitnorth ebit marginnorth cosmet household person
compani report secur llc estim
north america cl net america cl oper incom sale sale incom incom incom america cl net america cl oper incom sale sale incom incom incom eurasia cl net eurasia cl oper incom sale sale incom incom incom colgate-palmol compani
compani report secur llc estim
cl net cl oper incom sale sale incom incom incom pacif cl net pacif cl oper incom sale sale incom incom incom valuat million per share impli cl net cl oper incom sale incom incom incom cosmet household person
price target
price target assum price-to-earnings ev-to-ebitda multipl risk price
target includ increment fx headwind local brand competit materi slowdown emerg
cl one attract geograph profil core hpc stapl view believ
cl strong market share across develop world defens expect sustain mid-singl
digit growth driven growth spend power global middl class howev valuat
reflect
co base new york new york lead consum product compani
produc market oral care home care person care pet nutrit product compani
signific intern presenc market product countri territori world-wide
brand portfolio includ namesak colgat palmol brand also includ number
global brand includ ajax irish spring hill scienc diet softsoap speed stick suavitel
tom main www colgat com
